Shinji Atagi
- Pulmonary and Respiratory Medicine top 0.5%
- Oncology top 0.5%
- Molecular Biology top 10%
- Epidemiology top 5%
- Cancer Research top 5%
- Co-authors
- Nobuyuki YamamotoAkihiro TamiyaKazuhiko NakagawaKyoichi OkishioToyoaki HidaKōichi GotoYoshihiko TaniguchiTakashi Seto
- Topics
- Lung Cancer Treatments and Mutations (128 papers)Lung Cancer Diagnosis and Treatment (68 papers)Lung Cancer Research Studies (66 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Shinji Atagi
175 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Pulmonary and Respiratory Medicine 3.3k
- Oncology 3.2k
- Molecular Biology 819
- Epidemiology 491
- Cancer Research 430
Countries citing papers authored by Shinji Atagi
This map shows the geographic impact of Shinji Atagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinji Atagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinji Atagi more than expected).
Fields of papers citing papers by Shinji Atagi
This network shows the impact of papers produced by Shinji Atagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinji Atagi. The network helps show where Shinji Atagi may publish in the future.
Co-authorship network of co-authors of Shinji Atagi
This figure shows the co-authorship network connecting the top 25 collaborators of Shinji Atagi. A scholar is included among the top collaborators of Shinji Atagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinji Atagi. Shinji Atagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 31 | |
| 7 | 4 | |
| 8 | 31 | |
| 9 | 8 | |
| 10 | 35 | |
| 11 | 6 | |
| 12 | 4 | |
| 13 | 53 | |
| 14 | Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 studybreakdown → | 561 |
| 15 | 2 | |
| 16 | Carboplatin plus either docetaxel or paclitaxel for Japanese patients with advanced non-small cell lung cancer. | 6 |
| 17 | 22 | |
| 18 | 1 | |
| 19 | 1 | |
| 20 | 12 |
About Shinji Atagi
Shinji Atagi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology, having authored 182 papers that have together received 4.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (128 papers), Lung Cancer Diagnosis and Treatment (68 papers) and Lung Cancer Research Studies (66 papers). The work is most often cited by research in Oncology (3.2k citations), Pulmonary and Respiratory Medicine (3.3k citations) and Cancer Research (430 citations). Shinji Atagi has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Nobuyuki Yamamoto, Akihiro Tamiya, Kazuhiko Nakagawa, Kyoichi Okishio, Toyoaki Hida, Kōichi Goto, Yoshihiko Taniguchi, Takashi Seto, Isamu Okamoto and Motohiro Tamiya. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.